Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
American Journal of Human Genetics
|
November 3, 2023
Response to Luzzatto et al
Renee C Geck, Nicholas R Powell, Maitreya J Dunham
American Journal of Human Genetics
|
January 21, 2023
Functional interpretation, cataloging, and analysis of 1,341 glucose-6-phosphate dehydrogenase variants
Renee C Geck, Nicholas R Powell, Maitreya J Dunham
Clinical Pharmacology and Therapeutics
|
July 27, 2021
Mapping the miRNA-mRNA Interactome in Human Hepatocytes and Identification of Functional mirSNPs in Pharmacogenes
Nicholas R Powell, Harrison Zhao, Joseph Ipe, et al.
Clinical Pharmacology and Therapeutics
|
August 3, 2022
Evaluation of US Food and Drug Administration Drug Label Recommendations for Coadministration of Antivirals and Acid-Reducing Agents
Tyler Shugg, Nicholas R Powell, Patrick J Marroum, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 22, 2024
Functional Analysis of G6PD Variants Associated With Low G6PD Activity in the All of Us Research Program
Nicholas R Powell, Renee C Geck, Dongbing Lai, et al.
Cancer Reports (Hoboken, N.J.)
|
July 30, 2022
Quantification of spatial pharmacogene expression heterogeneity in breast tumors
Nicholas R Powell, Rebecca M Silvola, John S Howard, et al.
Genetics
|
November 28, 2024
Functional analysis of G6PD variants associated with low G6PD activity in the All of Us Research Program
Nicholas R Powell, Renee C Geck, Dongbing Lai, et al.
Frontiers in Oncology
|
February 17, 2022
Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report
Nicholas R Powell, Tyler Shugg, Reynold C Ly, et al.
Cell Stress & Chaperones
|
May 25, 2015
High-throughput screening system for inhibitors of human Heat Shock Factor 2
Levi M Smith, Dwipayan Bhattacharya, Daniel J Williams, et al.
Clinical Pharmacology and Therapeutics
|
June 8, 2026
How Drug-Drug Interaction Studies Inform Drug Labeling: A Survey of US Food and Drug Administration-Approved New Molecular Entities from 1998 to 2022
Tyler Shugg, Ashley N Springer, Yemi Gafari, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
American Journal of Human Genetics
|
November 3, 2023
Response to Luzzatto et al
Renee C Geck, Nicholas R Powell, Maitreya J Dunham
American Journal of Human Genetics
|
January 21, 2023
Functional interpretation, cataloging, and analysis of 1,341 glucose-6-phosphate dehydrogenase variants
Renee C Geck, Nicholas R Powell, Maitreya J Dunham
Clinical Pharmacology and Therapeutics
|
July 27, 2021
Mapping the miRNA-mRNA Interactome in Human Hepatocytes and Identification of Functional mirSNPs in Pharmacogenes
Nicholas R Powell, Harrison Zhao, Joseph Ipe, et al.
Clinical Pharmacology and Therapeutics
|
August 3, 2022
Evaluation of US Food and Drug Administration Drug Label Recommendations for Coadministration of Antivirals and Acid-Reducing Agents
Tyler Shugg, Nicholas R Powell, Patrick J Marroum, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 22, 2024
Functional Analysis of G6PD Variants Associated With Low G6PD Activity in the All of Us Research Program
Nicholas R Powell, Renee C Geck, Dongbing Lai, et al.
Cancer Reports (Hoboken, N.J.)
|
July 30, 2022
Quantification of spatial pharmacogene expression heterogeneity in breast tumors
Nicholas R Powell, Rebecca M Silvola, John S Howard, et al.
Genetics
|
November 28, 2024
Functional analysis of G6PD variants associated with low G6PD activity in the All of Us Research Program
Nicholas R Powell, Renee C Geck, Dongbing Lai, et al.
Frontiers in Oncology
|
February 17, 2022
Life-Threatening Docetaxel Toxicity in a Patient With Reduced-Function CYP3A Variants: A Case Report
Nicholas R Powell, Tyler Shugg, Reynold C Ly, et al.
Cell Stress & Chaperones
|
May 25, 2015
High-throughput screening system for inhibitors of human Heat Shock Factor 2
Levi M Smith, Dwipayan Bhattacharya, Daniel J Williams, et al.
Clinical Pharmacology and Therapeutics
|
June 8, 2026
How Drug-Drug Interaction Studies Inform Drug Labeling: A Survey of US Food and Drug Administration-Approved New Molecular Entities from 1998 to 2022
Tyler Shugg, Ashley N Springer, Yemi Gafari, et al.
Page
of 2